Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains 
One Percent Rule Checklist For Safer Forex Trading Risk 
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10% 
Baidu Shares Rise in Hong Kong After Apollo Go Robotaxi Launch in Abu Dhabi 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
Syrah Resources and Tesla Extend Deadline on Graphite Supply Dispute to March 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
SK Telecom Co. has released a mobile app-based DNA testing service dubbed care8 DNA in partnership with its joint venture Invites Healthcare Co. and bio firm Macrogen Inc.
The subscription-based setting allows users to sign up for 29 types of genetic testing, such as for nicotine reliance and hair loss.
Users will receive DNA test kits at home, which they would send back to SK Telecom with their saliva for analysis.
Test results will be available on the care8 DNA app after two weeks.
According to SK Telecom, their DNA service, which costs 99,000 won for a one-year subscription, is more affordable than local direct-to-consumer (DTC) genetic tests.
The app also provides other services, such as personalized health coaching. More genetic tests would also be introduced.
SK Telecom, South Korea's largest mobile carrier, increased its investment in Israel-based startup Nano-X Imaging Ltd in June to boost its presence in the digital health care sector.
The global DTC genetic testing market is expected to increase to $6.4 billion in 2028 from $824 million in 2018.
